Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · IEX Real-Time Price · USD
1.110
-0.030 (-2.63%)
Apr 26, 2024, 4:30 PM EDT - Market closed
Co-Diagnostics Revenue
In the year 2023, Co-Diagnostics had annual revenue of $6.81M, a decrease of -80.09%. Revenue in the quarter ending December 31, 2023 was $3.56M with 153.67% year-over-year growth.
Revenue (ttm)
$6.81M
Revenue Growth
-80.09%
P/S Ratio
5.09
Revenue / Employee
$43,949
Employees
155
Market Cap
34.70M USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 6.81M | -27.41M | -80.09% |
| Dec 31, 2022 | 34.22M | -63.67M | -65.04% |
| Dec 31, 2021 | 97.89M | 23.33M | 31.30% |
| Dec 31, 2020 | 74.55M | 74.34M | 34,579.90% |
| Dec 31, 2019 | 214.97K | 175.06K | 438.63% |
| Dec 31, 2018 | 39.91K | 32.25K | 420.90% |
| Dec 31, 2017 | 7.66K | - | - |
| Dec 31, 2016 | 0 | - | - |
| Dec 31, 2015 | 10.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fortress Biotech | 84.51M |
| Owlet | 54.01M |
| LENSAR | 42.16M |
| electroCore | 16.03M |
| Cyclo Therapeutics | 1.08M |
CODX News
- 2 days ago - Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast - PRNewsWire
- 3 days ago - Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan - PRNewsWire
- 15 days ago - Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event - PRNewsWire
- 23 days ago - Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions - PRNewsWire
- 5 weeks ago - Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address - PRNewsWire
- 5 weeks ago - Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England - PRNewsWire
- 6 weeks ago - Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results - PRNewsWire
- 7 weeks ago - Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test - PRNewsWire